RE: Inhalation Delivery27 Sep 2022 09:24
In theory Lanstead don’t actually need to be selling at these prices. Only if it’s over the 2p benchmark.
Lanstead have the money sat in a pot. It started out at £1.65m and they pay NFX each month.
To date they will have handed over circa £200-250k or thereabouts given the VWAP since March.
If the sp sat at this level till the end of the subscription next October they would only have to shell out another 300k or so. So they’d be left with the remain £1m for themselves and the shares.
Now you wouldn’t expect a reputable company like theirs to have people sowing doubt about their investments….